Advanced Practice Midwife in Bedford, NH Accepting Medicare
7 Advanced Practice Midwife nurses found. Showing 1 - 7
 Ms. Marie-claire Fisher, ARNP, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 5 Washington Pl, Dartmouth Hitchcock - Obstetrics & Gynecology, Bedford, NH 03110 Phone: 603-695-2900 |
Shawne S Broderick, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 5 Washington Pl, Bedford, NH 03110 Phone: 603-695-2900 |
Bekah Lf Kittredge, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 5 Washington Pl, Bedford, NH 03110 Phone: 603-695-2900 Fax: 603-727-7770 |
Deborah Black, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 5 Washington Pl, Dartmouth Hitchcock - Ob/gyn, Bedford, NH 03110 Phone: 603-629-8335 |
Kathryn C Hoyt, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 5 Washington Pl, Dartmouth Hitchcock - Ob/gyn, Bedford, NH 03110 Phone: 603-695-2900 |
Cassandra Lynne Montminy, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 5 Washington Pl, Bedford, NH 03110 Phone: 603-695-2900 Fax: 603-695-2919 |
Kathrine Yvonne Krupnik, APRN-CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 5 Washington Pl, Bedford, NH 03110 Phone: 603-695-2815 |
News Archive
Preoperative cerebral oxygen saturation could be a risk marker for adverse cardiac surgery outcome
A study published in the January 2011 issue of Anesthesiology is one of the first to show that low preoperative cerebral oxygen saturation (ScO2) could be an important physiological risk marker for adverse outcome in cardiac surgery patients.
Cosmetic surgery industry continues to grow in the U.S., says AACS survey
A procedural survey conducted by the American Academy of Cosmetic Surgery says more than 17 million cosmetic surgery procedures were performed in the United States in 2009.
Tocagen's Toca 511 & Toca FC receives FDA orphan drug designation for treatment of glioblastoma
Tocagen Inc., a clinical-stage immuno-oncology company, today announced that the U.S. Food and Drug Administration has granted orphan drug designation to the company's lead immuno-oncology product candidate, Toca 511 & Toca FC, for the treatment of glioblastoma.
O-glycosylation of SARS-CoV-2 spike protein in insect and human cell lines
The mapping of O-glycosites requires instruments that can support electron transfer dissociation (ETD) fragmentation. In a new study published on the bioRxiv preprint server, researchers report their results on whether O-glycosylation patterns affect immunogens for vaccine development.
› Verified 2 days ago
Nurse Practitioner
Physician Assistant
Registered Nurse
Advanced Practice Midwife